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BACKGROUND: We assessed expectations to improve
cardiovascular disease risk factors (CVD-RF) in partici-
pants to a health promotion program.
PARTICIPANTS AND METHODS: Blood pressure (BP),
blood glucose (BG), blood total cholesterol (TC), body
mass index (BMI), and self-reported smoking were
assessed in 1,598 volunteers from the general public
(men: 40%; mean age: 56.7±12.7 years) participating in
a mobile health promotion program in the Vaud canton,
Switzerland. Participants were asked about their expec-
tation to have their CVD-RF improved at a next visit
scheduled 2–3 years later.
RESULTS: Expectation for improved control was found
in 90% of participants with elevated BP, 91% with
elevated BG, 45% with elevated TC, 44% who were
overweight, and 35% who were smoking. Expectation
for TC improvement was reported more often by men,
persons with high level of TC, and persons who had
consulted a doctor in the past 12 months. Expectations
to lose weight and to quit smoking were found more
often in younger persons than the older ones.
CONCLUSION: Volunteers from the general population
participating in a health promotion program expected
improved control more often for hypertension and dys-
glycemia than for dyslipidemia, overweight and smoking.
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INTRODUCTION
Elevated blood pressure (BP), elevated blood glucose (BG),
elevated total cholesterol (TC), smoking and obesity are major
modifiable cardiovascular disease risk factors (CVD-RF)1 How-
ever, awareness related to CVD-RF is often poor in the general
public,2 and a large proportion of the population has poor
control of CVD-RF.3 Improvement in CVD-RF levels in the
population can be obtained either by public health measures
that target the entire population or by screening and treatment
of individuals with high levels of CVD-RF.4 The latter strategies
depend on the cooperation and willingness of the targeted
individuals to change their behaviors (i.e., lifestyle, nutrition)
and adhere to treatment.5
At an individual level, several factors influence health
behaviors, including awareness of having CVD-RF and of the
associated health risk, perceived benefit that would result from
CVD-RF improvement and self-efficacy for such an improve-
ment, and, more generally, various social and other factors
that influence empowerment to adopt healthy behaviors.6–11
Few studies have addressed individuals’ expectations for
improved level of CVD-RF upon being advised to do so12 and
we are not aware of any such study in nonclinical settings.
As part of a community-based health promotion program
including a screening and counseling component on CVD-RF in
participants of the general public,13 we asked participants on
their expectations to have CVD-RF improved at a next scheduled
visit after being informed on their risk factors and their
significance. We also examined whether expectation for im-
provedCVD-RF varied according to age, sex, and risk factor level.
METHODS
The Health Promotion Program has been previously de-
scribed.13 Briefly, the “Ligues contre les maladies cardiovascu-
laires” and the “Ligues de la santé” (http://www.liguesde
lasante.ch/) (both are non-profit health organizations) run a
Health Promotion Program, which aims at improving knowl-
edge and control of CVD-RF in the population (“Bilan &
Conseils Santé”, http://www.bilanconseilsante.ch/). This pro-
gram originated from the former Swiss National Fund Program
NRP1A (1985) that started in 1991 with a pilot study and was
then expanded to the present broader intervention.13 The
program is given through a mobile unit, i.e., a bus adequately
equipped and staffed with 2 trained health educators under
medical supervision. Attendance to the program was open to
all adults of the general population, at a cost of 30 CHF (~US
$25), and was announced through advertisements in various
mass media. The program took place throughout the entire
Canton of Vaud, which is located in the western, French-
speaking part of Switzerland and accounts for 9% of the Swiss
population (7.5 million). This study is based on the data of all
participants in 2006.
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The program consisted of a 30-minute screening and
counseling session. Participants were asked about their ex-
pectation to improve their CVD-RF after the counseling part.
Screening
Weight and height were measured and body mass index (BMI)
was calculated (kg/m2). Blood pressure (BP) reading was
measured with an automated oscillometric device (Boso Med-
icus, Bosch) in a sitting position after at least 5 minutes of rest.
BP was measured a second time 5–10 min later if the first
reading was ≥140/90 mmHg, and the second reading was
then considered. Blood glucose (BG) and total cholesterol (TC)
were determined on capillary blood and analyses made with a
dry chemical analyzer (Ektachem DT60, Eastman Kodak). The
health educators administered a structured questionnaire to
assess the smoking status, nationality, occupation, and when
was the last visit to a doctor.
Assessment of motivation for behavior change (i.e., with
respect to smoking, diet, and physical activity) was based on
the transtheoretical model of stage of change.8
Counseling
Based on results, the officers provided a 15-minute explana-
tion and counseling. Counseling was tailored to the stage of
change14 using brief motivational interviewing.11,15
A card summarizing levels of CVD-RF and related risk of CVD
(by means of colored bar graphs: low-risk in green, medium-risk
in orange, and high-risk in red) was given to all participants. Low
risk was defined according to the guidelines of the Swiss Society
for Cardiology,16 i.e., BP <140/90 mmHg, fasting BG
<6.1 mmol/L (<7.8 if non-fasting), TC <5.0 mmol/L, BMI
<25 kg/m2, and no smoking. High-risk was defined as BP
≥160/95mmHg, fastingBG≥7.0mmol/L (≥11.1 if non-fasting),
TC ≥6.5 mmol/L, BMI ≥30 kg/m2, and smoking ≥10 cigarettes
per day. Medium risk was defined for intermediate values.
Expectation to Improve CVD-RF
After counseling, all participants were systematically invited to
be seen again at a next visit 2–3 years later to assess progress
in CVD-RF control. Participants were then asked about their
expectations on CVD-RF change at this next visit, using the
following question “At which category of risk do you expect to
be at the next scheduled visit?” Answers included expectation to
have CVD-RF in the same current risk category, or, for those in
the medium or high-risk categories, expectation to have CVD-
RF improved to a lower risk category. Among smokers, being in
the pre-contemplation stage of change was considered as an
expectation not to quit smoking, whereas being in the contem-
plation, preparation, or action stages was considered as an
expectation to quit smoking.
Statistical Analyses
Prevalence and standard error were estimated for all CVD-RF.
For all participants with non-optimal level of CVD-RF, we
assessed the proportions who expected to have CVD-RF
improved. For each CVD-RF, we examined the associations
between expectation to reduce CVD-RF and age, sex, level of
CVD-RF, last visit to a doctor, nationality, and occupation with
multivariate logistic regression.
RESULTS
Table 1 shows the characteristics of the 1,598 subjects who
participated in the Health Promotion Program in 2006.
Participants were more often female and middle-aged (75%
were 45–74 years old). Of the participants, 83% were of Swiss
nationality; 10% were highly skilled employee or manager, 31%
skilled employee, 17% skilled or unskilled worker, and 42%
other (mostly retired).
Figure 1 shows the proportion of participants with each CVD-
RF who expected to improve their CVD-RF. Most participants
with elevated BP or elevated BG expected improvement in their
risk factor, whereas less than half of the participants with
elevated TC or elevated BMI expected improvement in their risk
factor. The majority of smokers did not expect to quit smoking.
Table 2 shows the association between expectation to
improve CVD-RF and selected characteristics (all analyses
are adjusted for occupation and nationality). Expectation to
reduce BP or to reduce BG at the next visit was not associated
with sex, age, and CVD-RF. Expectation to reduce TC was
associated with high level of TC and male sex, but not with age.
Expectation to reduce BMI was associated with young age, but
not with sex and BMI level. Finally, expectation to quit smoking
was associated with young age, but not with sex and number
Table 1. Characteristics of the Participants to the Health Promotion
Program in 2006 (N=1,598)
Men Women
N 635 963
Mean age (SD), year 56.1 (13.1) 57.0 (12.3)
Mean body mass index (SD), kg/m2 26.8 (3.5) 24.9 (4.2)
Body mass index categories (SE), %
Normal weight (BMI <25.0) 32 (2) 57 (2)
Overweight (BMI 25.0–29.9) 52 (2) 32 (2)
Obese (BMI >=30) 16 (2) 11 (1)
Mean systolic blood pressure (SD), mm Hg 135 (15) 126 (16)
Mean diastolic blood pressure (SD),
mm Hg
81 (10) 76 (9)
Blood pressure categories (SE), %
<140/90 mm Hg 65 (2) 82 (1)
140–159/90–94 mm Hg 25 (2) 13 (1)
≥160/95 mm Hg 10 (1) 5 (1)
Anti-hypertensive treatment (SE), % 15 (1) 15 (1)
Mean total cholesterol (SD), mmol/L 5.6 (1.0) 5.7 (1.0)
Total cholesterol categories (SE), %
<5.0 mmol/L 27 (2) 27 (1)
5.0–6.4 mmol/L 53 (2) 52 (2)
≥6.5 mmol/L 20 (2) 21 (1)
Lipid lowering treatment (SE), % 11 (1) 7 (1)
Mean blood glucose (SD), mmol/L 6.7 (1.7) 6.4 (1.2)
Blood glucose categories (SE), %
<6.1 mmol/L (non-fasting: <7.8) 81 (2) 88 (1)
6.1–6.9 mmol/L (7.8–11.0) [impaired
glucose tolerance]
16 (1) 10 (1)
≥7.0 mmol/L(≥11.1) [diabetes] 3 (1) 1 (0)
Smoking status (SE), %
Non-smoker 40 (2) 61 (2)
Past smoker 42 (2) 26 (1)
Smoker 18 (2) 13 (1)
Moderate (<15 cig/d) 9 (1) 7 (1)
Heavy (≥15 cig/d) 8 (1) 6 (1)
Doctor visit in the past 12 months 68 (2) 86 (1)
616 Chiolero et al.: Expectation to Improve Cardiovascular Risk Factors JGIM
of cigarettes smoked. Having visited a doctor in the previous
year was associated with expectation to improve TC, but not
with expectation to improve the other risk factors. Being
treated for any CVD-RF was not associated with expectations
for improvement (data not shown).
DISCUSSION
Our study shows that among participants of a mobile Health
Promotion Program open to the general public, expectation to
improvemodifiable cardiovascular risk factors (CVD-RF) differed
largely between the considered risk factors. Whereas almost all
participants with elevated BP or with elevated BG expected
improved levels at the next scheduled visit, more than half of
those with elevated TC or with elevated BMI did not expect
improvement, and only one third of smokers expected to quit
smoking. Younger participants were more confident that they
would reduce BMI or quit smoking than older ones, while men
expectedmore often to be able to reduce TC thanwomen. Having
visited a doctor in the preceding year was not associatedwith the
expectation to improve CVD-RF, excepted for elevated TC.
Strengths of our study are the large sample size and a
population-based design, which increased the external validity
of our findings. The distribution of CVD-RF was roughly similar
in our study as in a recent survey in the main city of the Canton
of Vaud,17 which suggests that the participants of our study are
roughly representative of the general population. However, as
participation in our program was voluntary and submitted to a
fee, participantsmay tend to be healthier andwealthier than the
actual population (healthy volunteer effect).18 Hence, our
results may underestimate the prevalence of CVD-RF and
overestimate favorable attitudes for behavior change.
Another limitation is that expectation to reduce CVD-RF was
evaluated through an administered questionnaire that has not
been formally validated. Administration of the questionnaire by
health educators may also lead the participants to inflate their
expectation to improve CVD-RF (social desirability bias).19
Furthermore, asking participants about their expectation after
providing them with explanations about the need for CVD-RF
control may alter their true beliefs and expectation for CVD-RF
improvement (perhaps in direction of overexpectation).
In this study, we did not ask the participants about specific
steps they should take to improve CVD-RF. The questionnaire
used to assess expectations was simple. More sophisticated
questionnaires should address underlying reasons and beliefs
for the answers provided and how improvement will be achieved.
We have previously shown that our screening and counseling
program did improve CVD-RF in high-risk participants, but not
in low-risk participants.13 This study suggests that the assess-
ment of expectation for improved CVD-RF may be a valuable
tool for tailoring counseling and treatment. Further studies will
need to examine, using a prospective design, whether expecta-
tion to improve CVD-RF predicts behavior change, medication
compliance, and actual CVD-RF improvement.
Much remains to be done to improve the effectiveness of
delivering individual-based interventions for CVD preven-
Table 2. Factors Associated with Expectation to Reduce Blood
Pressure (BP), Blood Glucose (BG), Total Cholesterol (TC) or Body
Mass Index (BMI), or to Quit Smoking in Participants with Elevated
BP, Elevated BG, Elevated TC, Overweight and Smokers
OR* 95% CI p value
Participants
with
elevated
BP
<60 yr vs ≥60 yr 2.0 0.8 4.9 0.12
Men vs women 0.8 0.4 1.6 0.54
High vs medium
BP†
0.9 0.4 2.0 0.88
Doctor visit in
the past 12
months vs not
0.9 0.4 2.0 0.73
Participants
with
elevated
BG
<60 yr vs ≥60 yr 1.5 0.5 4.8 0.50
Men vs women 0.5 0.2 1.5 0.24
High vs medium
glucose‡
0.5 0.1 1.5 0.20
Doctor visit in
the past 12
months vs not
0.8 0.2 3.0 0.72
Participants
with
elevated
TC
<60 yr vs ≥60 yr 1.3 1.0 1.7 0.063
Men vs women 1.5 1.2 2.0 0.001
High vs medium
TC§
2.3 1.7 3.0 <0.001
Doctor visit in
the past 12
months vs not
1.4 1.0 1.9 0.028
Participants
with
overweight
<60 yr vs ≥60 yr 3.0 2.1 4.2 <0.001
Men vs women 0.8 0.6 1.1 0.19
High vs medium
BMI§
1.3 0.9 1.8 0.18
Doctor visit in the
past 12 months
vs not
0.9 0.6 1.2 0.40
Participants
reporting
smoking
<60 yr vs ≥60 yr 3.0 2.1 4.2 <0.001
Men vs women 0.8 0.6 1.1 0.19
Heavy vs moderate
smoker¶
1.3 0.9 1.8 0.18
Doctor visit in
the past 12
months vs not
0.9 0.6 1.2 0.40
*For each risk factor, the OR is adjusted for age, sex, level of the risk
factor, having visited a doctor in the past 12 months, nationality and
occupation but not to the other risk factors.
† Medium BP: 140–159/90–94 mm Hg; high BP: ≥160/95 mmHg
‡.Medium fasting BG: 6.0–6.9 mmol/L (non-fasting: 7.8–11.0) [impaired
glucose tolerance]; high fasting BG: ≥7.0 mmol/L (non-fasting: ≥11.1)
[diabetes]
§Medium TC: 5.0–6.4 mmol/L; high TC: ≥6.5 mmol/L
║Medium BMI: 25.0–29.9 kg/m2 (overweight); high BMI: ≥30.0 kg/m2
(obesity)
¶Moderate smoker: <15 cigarettes/day; heavy smoker: ≥15 cigarettes/
day
OR odds ratio; CI: confidence interval.
Figure 1. Proportion of participants with elevated blood pressure
(BP), elevated blood glucose (BG), elevated total cholesterol (TC),
overweight and smoking who expected improved control at a next
visit.
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tion.20 Our study shows that expectation to improve modifiable
CVD-RF largely depends on which specific CVD-RF is consid-
ered. The significance of these differences and the usefulness
of expectation-based approaches to actually improve behaviors
and treatment will need to be addressed in prospective studies.
Pending more definite answers to these questions, the assess-
ment by health professionals of a person’s expectation to
improve CVD-RF is simple and may be a useful tool for
improving counseling, and eventually behavior change and
CVD-RF control.
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